Allschwil
Our J&J site in Allschwil, Basel area, was originally established as the headquarters of Actelion, a leading biopharmaceutical company focused on the discovery, development and commercialization of innovative drugs for diseases with significant unmet medical needs, most notably in pulmonary arterial hypertension. In June 2017 Actelion was acquired, becoming one of the Janssen Pharmaceutical Companies of Johnson & Johnson. With our Campus in Allschwil, J&J has an R&D Center of Excellence in Switzerland to attain and sustain world-class performance and value